Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells.

Br. J. Cancer. 2018-02; 
LiPeng,ChenJinbo,KashiwagiEiji,MizushimaTaichi,HanBin,InoueSatoshi,IdeHiroki,IzumiKoji,MiyamotoHir
Products/Services Used Details Operation
Peptide Synthesis … In addition, 18-amino acid peptides of SgI containing the LxxLL motif (wild-type: MKPNIIFVLSLLLILEKQ) or the LxxAA motif (mutant: MKPNIIFVLSLAAILEKQ) were obtained from GenScript (Piscataway, NJ, USA). Figure 1 Figure 1 … Get A Quote

摘要

We previously demonstrated that a seminal plasma protein, semenogelin I (SgI), functioned as an androgen receptor (AR) coactivator. Meanwhile, several short sequence motifs in AR coregulators, such as LxxLL (L=leucine), have been shown to mediate specific interactions with AR.

关键词

XML 地图